Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Names Sandra Leung Senior Vice President And General Counsel
2/16/2007
-
Onmark Signs Multisource Product Contract With Bristol-Myers Squibb
2/14/2007
-
The Day In Review: Will Sanofi-Aventis (France) Merge With Bristol-Myers Squibb Company?
1/30/2007
-
Bristol-Myers Squibb Company Reports Financial Results For The Fourth Quarter And Twelve Months Of 2006 And Announces EPS Guidance For 2007
1/25/2007
-
Bristol-Myers Squibb Company To Announce Results For The Fourth Quarter And Full Year Of 2006 On January 25
1/17/2007
-
The Day In Review: Bristol-Myers Squibb Company In $1.2 Billion Pact With AstraZeneca PLC
1/11/2007
-
Canadian Federal Court Of Appeals Rules In Sanofi-Aventis (France)' Favor In The Canadian Plavix Notice Of Compliance Proceedings
12/28/2006
-
The Day In Review: Targacept, Inc. Climbs On AstraZeneca PLC Payment
12/27/2006
-
Bristol-Myers Squibb Company And Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement For Diabetes Compound Saxagliptin In Japan
12/27/2006
-
The Day In Review: Eli Lilly and Company Stops Brain Cancer Trial
12/22/2006
-
Albany Molecular Research, Inc. Announces Drug Discovery Research Collaboration With Bristol-Myers Squibb Company
12/21/2006
-
Second "Large Biotech" Interested In Devens, Massachusetts; More Jobs To Genetown
12/19/2006
-
MedaSorb Technologies Names Former Bristol-Myers Squibb Company Vice Chairman, William R. Miller, As Chairman Of The Board
12/19/2006
-
The Day In Review: BioSante Pharmaceuticals, Inc. Rises On FDA Approval
12/18/2006
-
OSI Pharmaceuticals, Inc. Grants License To Bristol-Myers Squibb Company Under Dipeptidyl Peptidase IV (DPIV) Patent Portfolio For The Treatment Of Type 2 Diabetes
12/14/2006
-
Bristol-Myers Squibb Company To Hold Investor Teleconference To Discuss Data Presented At American Society of Hematology Meeting
12/13/2006
-
The Day In Review: Deals Dominate Biotech News
12/12/2006
-
Bristol-Myers Squibb Company Release: ABILIFY(R) (Aripiprazole) Injection For Intramuscular Use For Adults With Agitation Associated With Schizophrenia Or Bipolar Mania Now Available
12/12/2006
-
Sanofi-Aventis (France) And Bristol-Myers Squibb Company Release: Preliminary Injunction Against Apotex Inc. Upheld On Appeal
12/11/2006
-
Bristol-Myers Squibb Company Reports Positive Results From SPRYCEL Trials UPDATE
12/11/2006